GE HealthCare Technologies Inc. $GEHC Shares Bought by KBC Group NV

KBC Group NV raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 28.5% in the 1st quarter, Holdings Channel reports. The institutional investor owned 129,427 shares of the company’s stock after buying an additional 28,693 shares during the period. KBC Group NV’s holdings in GE HealthCare Technologies were worth $9,212,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of GEHC. Laurel Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies during the 4th quarter worth $26,000. Optima Capital LLC purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $27,000. Godfrey Financial Associates Inc. purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $27,000. Montag A & Associates Inc. increased its position in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC increased its position in GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 262 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 1.0%

Shares of NASDAQ:GEHC opened at $61.41 on Thursday. The firm has a market capitalization of $27.93 billion, a PE ratio of 14.69, a price-to-earnings-growth ratio of 1.69 and a beta of 0.72. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The firm’s 50-day moving average is $63.65 and its two-hundred day moving average is $71.46.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a dividend of $0.035 per share. The ex-dividend date is Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.35%.

Wall Street Analyst Weigh In

Several research firms have weighed in on GEHC. Barclays decreased their target price on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th. Mizuho cut their price target on shares of GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. BNP Paribas Exane reduced their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. Argus decreased their price objective on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Tuesday, May 19th. Finally, BTIG Research reiterated a “buy” rating and issued a $75.00 price objective on shares of GE HealthCare Technologies in a research report on Monday, July 13th. Ten investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Hold” and an average target price of $76.41.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Peter J. Arduini purchased 4,169 shares of the company’s stock in a transaction on Thursday, April 30th. The stock was acquired at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the purchase, the chief executive officer directly owned 259,424 shares in the company, valued at approximately $15,544,686.08. The trade was a 1.63% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Rodney F. Hochman acquired 1,618 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were bought at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the transaction, the director directly owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought a total of 21,847 shares of company stock worth $1,361,355 over the last three months. 0.36% of the stock is owned by insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.